electroCore (ECOR) Change in Acquisitions & Divestments (2017 - 2025)

electroCore's (ECOR) quarterly Change in Acquisitions & Divestments came in at $4.5 million in Q1 2025, up 353.7% quarter-over-quarter from $1.0 million in Q4 2021.

electroCore (ECOR) Change in Acquisitions & Divestments (2017 - 2025) Analysis & Trends

electroCore's Change in Acquisitions & Divestments history runs 6 years deep, the most recent figure standing at $4.5 million for Q1 2025.

  • On a quarterly basis, Change in Acquisitions & Divestments changed N/A year-over-year to $4.5 million in Q1 2025; TTM through Mar 2025 was $20.8 million, a N/A change from a year earlier, with the FY2021 full-year figure at $23.3 million, up 41.21% from the prior year.
  • Change in Acquisitions & Divestments advanced to $4.5 million in Q1 2025 per ECOR's latest filing, from $1.0 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $8.0 million in Q3 2021 and bottomed at $1.0 million in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 181.51 Bn 174.21 Bn 6.27 Bn
2 Stryker 128.52 Bn 125.64 Bn 3.81 Bn
3 Medtronic 108.06 Bn 98.84 Bn 6.41 Bn
4 Boston Scientific 68.04 Bn 66.59 Bn 3.61 Bn
5 Edwards Lifesciences 47.64 Bn 43.97 Bn 1.29 Bn
6 GE HealthCare Technologies 28.45 Bn 26.17 Bn 1.98 Bn
7 Dexcom 28.41 Bn 27.29 Bn 750.30 Mn
8 Smith & Nephew 26.88 Bn 26.30 Bn -
9 Koninklijke Philips 25.42 Bn 22.29 Bn 2.07 Bn
10 electroCore 55,508.60 -8.77 Mn 8.36 Mn

Historic Data

Download Data
DateValue
Mar 31, 2025 4.54 Mn
Mar 31, 2025 4.54 Mn
Dec 31, 2021 1.00 Mn
Dec 31, 2021 1.00 Mn
Sep 30, 2021 8.00 Mn
Sep 30, 2021 8.00 Mn
Jun 30, 2021 7.30 Mn
Jun 30, 2021 7.30 Mn
Mar 31, 2021 7.00 Mn
Mar 31, 2021 7.00 Mn
Dec 31, 2020 6.00 Mn
Dec 31, 2020 6.00 Mn
Mar 31, 2020 10.50 Mn
Mar 31, 2020 10.50 Mn
Dec 31, 2019 18.50 Mn
Dec 31, 2019 18.50 Mn
Sep 30, 2019 20.50 Mn
Sep 30, 2019 20.50 Mn
Jun 30, 2019 21.37 Mn
Jun 30, 2019 21.37 Mn